Publikationen von F. Weber
Alle Typen
Zeitschriftenartikel (71)
2008
Zeitschriftenartikel
255 (Suppl. 2), S. 52 - 53 (2008)
IL2RA and IL7RA genes confer susceptibility for multiple sclerosis in two independent European populations. Journal of Neurology
Zeitschriftenartikel
9 (3), S. 259 - 263 (2008)
IL2RA and IL7RA genes confer susceptibility for multiple sclerosis in two independent European populations. Genes and Immunity 2007
Zeitschriftenartikel
13 (9), S. 1138 - 1145 (2007)
Time of interferon- β 1a injection and duration of treatment affect clinical side effects and acute changes of plasma hormone and cytokine levels in multiple sclerosis patients. Multiple Sclerosis
Zeitschriftenartikel
13 (Suppl. 2), S. S250 - S250 (2007)
Experimental autoimmune encephalomyelitis biomarkers indicate mechanisms mediating neurodegeneration. Multiple Sclerosis
Zeitschriftenartikel
116 (3), S. 164 - 168 (2007)
Migration of T-cell subsets in multiple sclerosis and the effect of interferon-beta 1a. Acta Neurologica Scandinavica
Zeitschriftenartikel
40 (5), S. 245 - 245 (2007)
Protein expression profiling of human glatiramer acetate (GA) and myelin basic protein (MBP) specific T cell lines from a multiple sclerosis (MS) patient and healthy donors. Pharmacopsychiatry
Zeitschriftenartikel
254 (Suppl. 3), S. 189 - 190 (2007)
Protein expression profiling of human glatiramer acetate specific T cell lines from a multiple sclerosis patient and healthy donors. Journal of Neurology
Zeitschriftenartikel
254 (Suppl. 3), S. 113 - 113 (2007)
MMP-2, MMP-9 and their inhibitors in ischaernic stroke. Gender differences and time course. Journal of Neurology
Zeitschriftenartikel
254 (Suppl. 3), S. 73 - 73 (2007)
Human antigen specific T cell lines express neurturin, a member of the GDNF family ligands. Journal of Neurology
Zeitschriftenartikel
- (1), S. 1 - 5 (2007)
Multiple Sklerose - Therapie schwerer Krankheitsverläufe. Neurotransmitter 2006
Zeitschriftenartikel
6 (19), doi:10.1186/1471-2377-6-19 (2006)
Monthly intravenous methylprednisolone in relapsing-remitting multiple sclerosis - reduction of enhancing lesions, T2 lesion volume and plasma prolactin concentrations. BMC Neurology
Zeitschriftenartikel
114, S. 368 - 373 (2006)
Interferon-β1b treatment modulates cytokines in patients with primary progressive multiple sclerosis. Acta Neurologica Scandinavica
Zeitschriftenartikel
181, S. 133 - 140 (2006)
Glatiramer acetate-specific human CD8+ T cells: Increased IL-4 production in multiple sclerosis is reduced by glatiramer acetate treatment. Journal of Neuroimmunology
Zeitschriftenartikel
26 (3), S. 346 - 347 (2006)
Combination therapy of lamotrigine and escitalopram may cause myoclonus. Journal of Clinical Psychopharmacology
Zeitschriftenartikel
26 (4), S. 431 - 431 (2006)
Olanzapine-induced oculogyric crisis. Journal of Clinical Psychopharmacology 2005
Zeitschriftenartikel
62 (2), S. 277 - 280 (2005)
Fatigue and regulation of the hypothalamo-pituitary-adrenal axis in multiple sclerosis. Archives of Neurology
Zeitschriftenartikel
115 (Suppl. 1), S. S99 - S99 (2005)
The cytokine pattern of glatiramer acetate reactive CD8+ T cell lines derived from MS patients and healthy volunteers. Clinical Immunology 2004
Zeitschriftenartikel
110 (6), S. 386 - 392 (2004)
Interferon beta-1b modulates serum sVCAM-1 levels in primary progressive multiple sclerosis. Acta Neurologica Scandinavica
Zeitschriftenartikel
251 (12), S. 1498 - 1501 (2004)
Autoantibody synthesis in primary progressive multiple sclerosis patients treated with interferon beta-1b. Journal of Neurology
Zeitschriftenartikel
251 (Suppl. Suppl. 3), S. 178 - 179 (2004)
White matter tract injury and the multiple sclerosis functional composite score. Journal of Neurology